- Home
- QGEN vs BXSL Comparison
QGEN vs BXSL Comparison
Compare QGEN & BXSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- BXSL
- Stock Information
- Founded
- QGEN 1986
- BXSL 2018
- Country
- QGEN Netherlands
- BXSL United States
- Employees
- QGEN N/A
- BXSL N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- BXSL Trusts Except Educational Religious and Charitable
- Sector
- QGEN Health Care
- BXSL Finance
- Exchange
- QGEN Nasdaq
- BXSL Nasdaq
- Market Cap
- QGEN 9.1B
- BXSL 7.5B
- IPO Year
- QGEN 1996
- BXSL N/A
- Fundamental
- Price
- QGEN $45.14
- BXSL $31.90
- Analyst Decision
- QGEN Buy
- BXSL Buy
- Analyst Count
- QGEN 8
- BXSL 6
- Target Price
- QGEN $50.53
- BXSL $31.38
- AVG Volume (30 Days)
- QGEN 1.5M
- BXSL 855.9K
- Earning Date
- QGEN 05-07-2025
- BXSL 05-07-2025
- Dividend Yield
- QGEN 2.92%
- BXSL 9.66%
- EPS Growth
- QGEN N/A
- BXSL N/A
- EPS
- QGEN 0.42
- BXSL 3.14
- Revenue
- QGEN $2,002,874,000.00
- BXSL $1,380,706,000.00
- Revenue This Year
- QGEN $6.11
- BXSL $9.80
- Revenue Next Year
- QGEN $6.10
- BXSL $6.52
- P/E Ratio
- QGEN $107.32
- BXSL $10.16
- Revenue Growth
- QGEN 3.31
- BXSL 16.76
- 52 Week Low
- QGEN $37.63
- BXSL $25.89
- 52 Week High
- QGEN $47.93
- BXSL $34.64
- Technical
- Relative Strength Index (RSI)
- QGEN 66.03
- BXSL 62.21
- Support Level
- QGEN $41.77
- BXSL $30.78
- Resistance Level
- QGEN $43.01
- BXSL $32.21
- Average True Range (ATR)
- QGEN 0.70
- BXSL 0.51
- MACD
- QGEN 0.24
- BXSL 0.11
- Stochastic Oscillator
- QGEN 93.82
- BXSL 82.79
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.